nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—CYP2C9—Diclofenamide—glaucoma	0.12	0.354	CbGbCtD
Eprosartan—CYP2C9—Dorzolamide—glaucoma	0.116	0.342	CbGbCtD
Eprosartan—CYP2C9—Methazolamide—glaucoma	0.103	0.304	CbGbCtD
Eprosartan—AGTR1—ACE Inhibitor Pathway—MAS1—glaucoma	0.0105	0.165	CbGpPWpGaD
Eprosartan—AGTR1—ACE Inhibitor Pathway—ACE2—glaucoma	0.00797	0.125	CbGpPWpGaD
Eprosartan—ABCC2—ABC-family proteins mediated transport—PEX19—glaucoma	0.00533	0.0836	CbGpPWpGaD
Eprosartan—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00178	0.028	CbGpPWpGaD
Eprosartan—AGTR1—ACE Inhibitor Pathway—NOS3—glaucoma	0.00175	0.0275	CbGpPWpGaD
Eprosartan—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00162	0.0255	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—OPN4—glaucoma	0.00141	0.0222	CbGpPWpGaD
Eprosartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00128	0.02	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—PTGFR—glaucoma	0.00127	0.0199	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00126	0.0198	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00119	0.0187	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.00114	0.0178	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00109	0.0171	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000983	0.0154	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000936	0.0147	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FN1—glaucoma	0.000932	0.0146	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000842	0.0132	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL1A—glaucoma	0.000838	0.0131	CbGpPWpGaD
Eprosartan—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.000824	0.0129	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—glaucoma	0.00079	0.0124	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—SLC6A13—glaucoma	0.000784	0.0123	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—FAS—glaucoma	0.000747	0.0117	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—glaucoma	0.00074	0.0116	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—C3—glaucoma	0.000736	0.0115	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—OPN4—glaucoma	0.000712	0.0112	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—TXN—glaucoma	0.000644	0.0101	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—PTGFR—glaucoma	0.000641	0.0101	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—SLC6A1—glaucoma	0.000574	0.009	CbGpPWpGaD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000561	0.00879	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000557	0.00874	CbGpPWpGaD
Eprosartan—Dyspepsia—Dorzolamide—glaucoma	0.000532	0.00089	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Timolol—glaucoma	0.00053	0.000887	CcSEcCtD
Eprosartan—Dyspnoea—Brinzolamide—glaucoma	0.00053	0.000886	CcSEcCtD
Eprosartan—Dyspepsia—Travoprost—glaucoma	0.00053	0.000886	CcSEcCtD
Eprosartan—Asthenia—Apraclonidine—glaucoma	0.000529	0.000885	CcSEcCtD
Eprosartan—Somnolence—Brinzolamide—glaucoma	0.000528	0.000884	CcSEcCtD
Eprosartan—Decreased appetite—Dorzolamide—glaucoma	0.000525	0.000879	CcSEcCtD
Eprosartan—Urticaria—Acetazolamide—glaucoma	0.000524	0.000876	CcSEcCtD
Eprosartan—Tremor—Clonidine—glaucoma	0.000524	0.000876	CcSEcCtD
Eprosartan—Dyspepsia—Brinzolamide—glaucoma	0.000523	0.000875	CcSEcCtD
Eprosartan—Pruritus—Apraclonidine—glaucoma	0.000522	0.000873	CcSEcCtD
Eprosartan—Body temperature increased—Acetazolamide—glaucoma	0.000521	0.000872	CcSEcCtD
Eprosartan—Fatigue—Dorzolamide—glaucoma	0.000521	0.000872	CcSEcCtD
Eprosartan—Tinnitus—Betaxolol—glaucoma	0.000521	0.000872	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.00052	0.000871	CcSEcCtD
Eprosartan—Fatigue—Travoprost—glaucoma	0.000519	0.000868	CcSEcCtD
Eprosartan—Ill-defined disorder—Clonidine—glaucoma	0.000519	0.000868	CcSEcCtD
Eprosartan—Pain—Dorzolamide—glaucoma	0.000517	0.000865	CcSEcCtD
Eprosartan—Insomnia—Pilocarpine—glaucoma	0.000517	0.000864	CcSEcCtD
Eprosartan—Decreased appetite—Brinzolamide—glaucoma	0.000517	0.000864	CcSEcCtD
Eprosartan—Pain—Travoprost—glaucoma	0.000515	0.000861	CcSEcCtD
Eprosartan—Constipation—Travoprost—glaucoma	0.000515	0.000861	CcSEcCtD
Eprosartan—Hyperglycaemia—Timolol—glaucoma	0.000515	0.000861	CcSEcCtD
Eprosartan—Paraesthesia—Pilocarpine—glaucoma	0.000513	0.000858	CcSEcCtD
Eprosartan—Asthenia—Bimatoprost—glaucoma	0.000513	0.000858	CcSEcCtD
Eprosartan—Fatigue—Brinzolamide—glaucoma	0.000512	0.000857	CcSEcCtD
Eprosartan—Angioedema—Clonidine—glaucoma	0.000511	0.000854	CcSEcCtD
Eprosartan—Dyspnoea—Pilocarpine—glaucoma	0.000509	0.000852	CcSEcCtD
Eprosartan—Pain—Brinzolamide—glaucoma	0.000508	0.00085	CcSEcCtD
Eprosartan—Somnolence—Pilocarpine—glaucoma	0.000508	0.00085	CcSEcCtD
Eprosartan—Depression—Timolol—glaucoma	0.000507	0.000849	CcSEcCtD
Eprosartan—Pruritus—Bimatoprost—glaucoma	0.000506	0.000846	CcSEcCtD
Eprosartan—Diarrhoea—Apraclonidine—glaucoma	0.000504	0.000844	CcSEcCtD
Eprosartan—Malaise—Clonidine—glaucoma	0.000504	0.000843	CcSEcCtD
Eprosartan—Dyspepsia—Pilocarpine—glaucoma	0.000503	0.000841	CcSEcCtD
Eprosartan—Chills—Betaxolol—glaucoma	0.000502	0.000839	CcSEcCtD
Eprosartan—Syncope—Clonidine—glaucoma	0.000501	0.000839	CcSEcCtD
Eprosartan—Feeling abnormal—Dorzolamide—glaucoma	0.000498	0.000833	CcSEcCtD
Eprosartan—Decreased appetite—Pilocarpine—glaucoma	0.000497	0.000831	CcSEcCtD
Eprosartan—Feeling abnormal—Travoprost—glaucoma	0.000496	0.00083	CcSEcCtD
Eprosartan—Conjunctivitis—Timolol—glaucoma	0.000494	0.000827	CcSEcCtD
Eprosartan—Gastrointestinal pain—Dorzolamide—glaucoma	0.000494	0.000827	CcSEcCtD
Eprosartan—Palpitations—Clonidine—glaucoma	0.000494	0.000826	CcSEcCtD
Eprosartan—Gastrointestinal pain—Travoprost—glaucoma	0.000492	0.000823	CcSEcCtD
Eprosartan—Loss of consciousness—Clonidine—glaucoma	0.000491	0.000822	CcSEcCtD
Eprosartan—Feeling abnormal—Brinzolamide—glaucoma	0.00049	0.000819	CcSEcCtD
Eprosartan—Pain—Pilocarpine—glaucoma	0.000488	0.000817	CcSEcCtD
Eprosartan—Constipation—Pilocarpine—glaucoma	0.000488	0.000817	CcSEcCtD
Eprosartan—Cough—Clonidine—glaucoma	0.000488	0.000816	CcSEcCtD
Eprosartan—Dizziness—Apraclonidine—glaucoma	0.000488	0.000816	CcSEcCtD
Eprosartan—Urticaria—Dorzolamide—glaucoma	0.00048	0.000803	CcSEcCtD
Eprosartan—Epistaxis—Timolol—glaucoma	0.00048	0.000803	CcSEcCtD
Eprosartan—Abdominal pain—Dorzolamide—glaucoma	0.000478	0.000799	CcSEcCtD
Eprosartan—Body temperature increased—Dorzolamide—glaucoma	0.000478	0.000799	CcSEcCtD
Eprosartan—Tension—Betaxolol—glaucoma	0.000477	0.000799	CcSEcCtD
Eprosartan—Sinusitis—Timolol—glaucoma	0.000477	0.000798	CcSEcCtD
Eprosartan—Chest pain—Clonidine—glaucoma	0.000476	0.000796	CcSEcCtD
Eprosartan—Arthralgia—Clonidine—glaucoma	0.000476	0.000796	CcSEcCtD
Eprosartan—Abdominal pain—Travoprost—glaucoma	0.000476	0.000796	CcSEcCtD
Eprosartan—Anxiety—Clonidine—glaucoma	0.000474	0.000793	CcSEcCtD
Eprosartan—Asthenia—Acetazolamide—glaucoma	0.000473	0.000792	CcSEcCtD
Eprosartan—Dizziness—Bimatoprost—glaucoma	0.000473	0.000791	CcSEcCtD
Eprosartan—Nervousness—Betaxolol—glaucoma	0.000473	0.000791	CcSEcCtD
Eprosartan—Urticaria—Brinzolamide—glaucoma	0.000472	0.00079	CcSEcCtD
Eprosartan—Feeling abnormal—Pilocarpine—glaucoma	0.000471	0.000787	CcSEcCtD
Eprosartan—Discomfort—Clonidine—glaucoma	0.00047	0.000787	CcSEcCtD
Eprosartan—Vomiting—Apraclonidine—glaucoma	0.000469	0.000784	CcSEcCtD
Eprosartan—ABCC2—NRF2 pathway—TGFB2—glaucoma	0.000468	0.00734	CbGpPWpGaD
Eprosartan—Muscle spasms—Betaxolol—glaucoma	0.000468	0.000783	CcSEcCtD
Eprosartan—Gastrointestinal pain—Pilocarpine—glaucoma	0.000467	0.000781	CcSEcCtD
Eprosartan—Hypersensitivity—Brimonidine—glaucoma	0.000466	0.00078	CcSEcCtD
Eprosartan—Dry mouth—Clonidine—glaucoma	0.000465	0.000779	CcSEcCtD
Eprosartan—Bradycardia—Timolol—glaucoma	0.000465	0.000778	CcSEcCtD
Eprosartan—Dermatitis—Apraclonidine—glaucoma	0.000464	0.000777	CcSEcCtD
Eprosartan—Headache—Apraclonidine—glaucoma	0.000462	0.000773	CcSEcCtD
Eprosartan—Rhinitis—Timolol—glaucoma	0.000458	0.000766	CcSEcCtD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—glaucoma	0.000457	0.00717	CbGpPWpGaD
Eprosartan—Tremor—Betaxolol—glaucoma	0.000456	0.000763	CcSEcCtD
Eprosartan—Asthenia—Brimonidine—glaucoma	0.000454	0.00076	CcSEcCtD
Eprosartan—Body temperature increased—Pilocarpine—glaucoma	0.000452	0.000755	CcSEcCtD
Eprosartan—Abdominal pain—Pilocarpine—glaucoma	0.000452	0.000755	CcSEcCtD
Eprosartan—Ill-defined disorder—Betaxolol—glaucoma	0.000451	0.000755	CcSEcCtD
Eprosartan—Diarrhoea—Acetazolamide—glaucoma	0.000451	0.000755	CcSEcCtD
Eprosartan—Rash—Bimatoprost—glaucoma	0.000451	0.000754	CcSEcCtD
Eprosartan—Dermatitis—Bimatoprost—glaucoma	0.00045	0.000753	CcSEcCtD
Eprosartan—Oedema peripheral—Timolol—glaucoma	0.00045	0.000753	CcSEcCtD
Eprosartan—Shock—Clonidine—glaucoma	0.000449	0.000751	CcSEcCtD
Eprosartan—Pruritus—Brimonidine—glaucoma	0.000448	0.000749	CcSEcCtD
Eprosartan—Headache—Bimatoprost—glaucoma	0.000448	0.000749	CcSEcCtD
Eprosartan—Thrombocytopenia—Clonidine—glaucoma	0.000447	0.000747	CcSEcCtD
Eprosartan—Hypersensitivity—Dorzolamide—glaucoma	0.000445	0.000745	CcSEcCtD
Eprosartan—Tachycardia—Clonidine—glaucoma	0.000445	0.000745	CcSEcCtD
Eprosartan—Hypersensitivity—Travoprost—glaucoma	0.000443	0.000742	CcSEcCtD
Eprosartan—Hyperhidrosis—Clonidine—glaucoma	0.000441	0.000738	CcSEcCtD
Eprosartan—Visual impairment—Timolol—glaucoma	0.00044	0.000736	CcSEcCtD
Eprosartan—Malaise—Betaxolol—glaucoma	0.000439	0.000734	CcSEcCtD
Eprosartan—Nausea—Apraclonidine—glaucoma	0.000438	0.000733	CcSEcCtD
Eprosartan—Hypersensitivity—Brinzolamide—glaucoma	0.000438	0.000733	CcSEcCtD
Eprosartan—Vertigo—Betaxolol—glaucoma	0.000437	0.000731	CcSEcCtD
Eprosartan—Syncope—Betaxolol—glaucoma	0.000436	0.00073	CcSEcCtD
Eprosartan—Dizziness—Acetazolamide—glaucoma	0.000436	0.00073	CcSEcCtD
Eprosartan—Anorexia—Clonidine—glaucoma	0.000435	0.000727	CcSEcCtD
Eprosartan—Asthenia—Dorzolamide—glaucoma	0.000434	0.000726	CcSEcCtD
Eprosartan—Asthenia—Travoprost—glaucoma	0.000432	0.000722	CcSEcCtD
Eprosartan—Palpitations—Betaxolol—glaucoma	0.00043	0.000719	CcSEcCtD
Eprosartan—Pruritus—Dorzolamide—glaucoma	0.000428	0.000715	CcSEcCtD
Eprosartan—Loss of consciousness—Betaxolol—glaucoma	0.000428	0.000715	CcSEcCtD
Eprosartan—Asthenia—Brinzolamide—glaucoma	0.000426	0.000713	CcSEcCtD
Eprosartan—Hypotension—Clonidine—glaucoma	0.000426	0.000713	CcSEcCtD
Eprosartan—Pruritus—Travoprost—glaucoma	0.000426	0.000712	CcSEcCtD
Eprosartan—Tinnitus—Timolol—glaucoma	0.000426	0.000712	CcSEcCtD
Eprosartan—Cough—Betaxolol—glaucoma	0.000425	0.00071	CcSEcCtD
Eprosartan—Nausea—Bimatoprost—glaucoma	0.000425	0.00071	CcSEcCtD
Eprosartan—AGTR1—G alpha (q) signalling events—EDN1—glaucoma	0.000423	0.00663	CbGpPWpGaD
Eprosartan—Hypersensitivity—Pilocarpine—glaucoma	0.000421	0.000704	CcSEcCtD
Eprosartan—Pruritus—Brinzolamide—glaucoma	0.00042	0.000703	CcSEcCtD
Eprosartan—Vomiting—Acetazolamide—glaucoma	0.000419	0.000702	CcSEcCtD
Eprosartan—Dizziness—Brimonidine—glaucoma	0.000419	0.0007	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—EDN1—glaucoma	0.000418	0.00655	CbGpPWpGaD
Eprosartan—Musculoskeletal discomfort—Clonidine—glaucoma	0.000416	0.000695	CcSEcCtD
Eprosartan—Myalgia—Betaxolol—glaucoma	0.000414	0.000693	CcSEcCtD
Eprosartan—Chest pain—Betaxolol—glaucoma	0.000414	0.000693	CcSEcCtD
Eprosartan—Arthralgia—Betaxolol—glaucoma	0.000414	0.000693	CcSEcCtD
Eprosartan—Diarrhoea—Dorzolamide—glaucoma	0.000414	0.000692	CcSEcCtD
Eprosartan—Headache—Acetazolamide—glaucoma	0.000413	0.000691	CcSEcCtD
Eprosartan—Anxiety—Betaxolol—glaucoma	0.000413	0.000691	CcSEcCtD
Eprosartan—Insomnia—Clonidine—glaucoma	0.000413	0.00069	CcSEcCtD
Eprosartan—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000412	0.00646	CbGpPWpGaD
Eprosartan—Diarrhoea—Travoprost—glaucoma	0.000412	0.000689	CcSEcCtD
Eprosartan—Asthenia—Pilocarpine—glaucoma	0.00041	0.000686	CcSEcCtD
Eprosartan—Paraesthesia—Clonidine—glaucoma	0.00041	0.000685	CcSEcCtD
Eprosartan—Discomfort—Betaxolol—glaucoma	0.000409	0.000685	CcSEcCtD
Eprosartan—Dyspnoea—Clonidine—glaucoma	0.000407	0.00068	CcSEcCtD
Eprosartan—Diarrhoea—Brinzolamide—glaucoma	0.000407	0.00068	CcSEcCtD
Eprosartan—Somnolence—Clonidine—glaucoma	0.000406	0.000678	CcSEcCtD
Eprosartan—Dry mouth—Betaxolol—glaucoma	0.000405	0.000678	CcSEcCtD
Eprosartan—Pruritus—Pilocarpine—glaucoma	0.000404	0.000676	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—OPN4—glaucoma	0.000403	0.00631	CbGpPWpGaD
Eprosartan—Dizziness—Dorzolamide—glaucoma	0.0004	0.000669	CcSEcCtD
Eprosartan—Rash—Brimonidine—glaucoma	0.000399	0.000668	CcSEcCtD
Eprosartan—Dermatitis—Brimonidine—glaucoma	0.000399	0.000667	CcSEcCtD
Eprosartan—Dizziness—Travoprost—glaucoma	0.000398	0.000666	CcSEcCtD
Eprosartan—Headache—Brimonidine—glaucoma	0.000397	0.000663	CcSEcCtD
Eprosartan—Decreased appetite—Clonidine—glaucoma	0.000397	0.000663	CcSEcCtD
Eprosartan—Fatigue—Clonidine—glaucoma	0.000393	0.000658	CcSEcCtD
Eprosartan—Dizziness—Brinzolamide—glaucoma	0.000393	0.000657	CcSEcCtD
Eprosartan—Nausea—Acetazolamide—glaucoma	0.000392	0.000655	CcSEcCtD
Eprosartan—Diarrhoea—Pilocarpine—glaucoma	0.000391	0.000654	CcSEcCtD
Eprosartan—Shock—Betaxolol—glaucoma	0.000391	0.000654	CcSEcCtD
Eprosartan—Tension—Timolol—glaucoma	0.00039	0.000653	CcSEcCtD
Eprosartan—Constipation—Clonidine—glaucoma	0.00039	0.000653	CcSEcCtD
Eprosartan—Pain—Clonidine—glaucoma	0.00039	0.000653	CcSEcCtD
Eprosartan—Thrombocytopenia—Betaxolol—glaucoma	0.000389	0.00065	CcSEcCtD
Eprosartan—Tachycardia—Betaxolol—glaucoma	0.000388	0.000648	CcSEcCtD
Eprosartan—Nervousness—Timolol—glaucoma	0.000386	0.000646	CcSEcCtD
Eprosartan—Vomiting—Dorzolamide—glaucoma	0.000384	0.000643	CcSEcCtD
Eprosartan—Hyperhidrosis—Betaxolol—glaucoma	0.000384	0.000642	CcSEcCtD
Eprosartan—Rash—Dorzolamide—glaucoma	0.000381	0.000638	CcSEcCtD
Eprosartan—Dermatitis—Dorzolamide—glaucoma	0.000381	0.000637	CcSEcCtD
Eprosartan—Rash—Travoprost—glaucoma	0.000379	0.000635	CcSEcCtD
Eprosartan—Dermatitis—Travoprost—glaucoma	0.000379	0.000634	CcSEcCtD
Eprosartan—Headache—Dorzolamide—glaucoma	0.000379	0.000634	CcSEcCtD
Eprosartan—Anorexia—Betaxolol—glaucoma	0.000379	0.000633	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000378	0.00593	CbGpPWpGaD
Eprosartan—Vomiting—Brinzolamide—glaucoma	0.000378	0.000632	CcSEcCtD
Eprosartan—Dizziness—Pilocarpine—glaucoma	0.000378	0.000632	CcSEcCtD
Eprosartan—Headache—Travoprost—glaucoma	0.000377	0.000631	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000376	0.0059	CbGpPWpGaD
Eprosartan—Nausea—Brimonidine—glaucoma	0.000376	0.000629	CcSEcCtD
Eprosartan—Feeling abnormal—Clonidine—glaucoma	0.000376	0.000629	CcSEcCtD
Eprosartan—Rash—Brinzolamide—glaucoma	0.000375	0.000627	CcSEcCtD
Eprosartan—Dermatitis—Brinzolamide—glaucoma	0.000374	0.000626	CcSEcCtD
Eprosartan—Gastrointestinal pain—Clonidine—glaucoma	0.000373	0.000624	CcSEcCtD
Eprosartan—Headache—Brinzolamide—glaucoma	0.000372	0.000623	CcSEcCtD
Eprosartan—Hypotension—Betaxolol—glaucoma	0.000371	0.000621	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—VEGFA—glaucoma	0.00037	0.0058	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—OPN4—glaucoma	0.000366	0.00573	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—C3—glaucoma	0.000365	0.00572	CbGpPWpGaD
Eprosartan—Angioedema—Timolol—glaucoma	0.000363	0.000608	CcSEcCtD
Eprosartan—Vomiting—Pilocarpine—glaucoma	0.000363	0.000608	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—PTGFR—glaucoma	0.000363	0.00568	CbGpPWpGaD
Eprosartan—Urticaria—Clonidine—glaucoma	0.000362	0.000606	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000362	0.000605	CcSEcCtD
Eprosartan—Abdominal pain—Clonidine—glaucoma	0.000361	0.000603	CcSEcCtD
Eprosartan—Body temperature increased—Clonidine—glaucoma	0.000361	0.000603	CcSEcCtD
Eprosartan—Rash—Pilocarpine—glaucoma	0.00036	0.000603	CcSEcCtD
Eprosartan—Dermatitis—Pilocarpine—glaucoma	0.00036	0.000602	CcSEcCtD
Eprosartan—Insomnia—Betaxolol—glaucoma	0.000359	0.000601	CcSEcCtD
Eprosartan—Nausea—Dorzolamide—glaucoma	0.000359	0.000601	CcSEcCtD
Eprosartan—Headache—Pilocarpine—glaucoma	0.000358	0.000599	CcSEcCtD
Eprosartan—Nausea—Travoprost—glaucoma	0.000358	0.000598	CcSEcCtD
Eprosartan—Vertigo—Timolol—glaucoma	0.000357	0.000597	CcSEcCtD
Eprosartan—Paraesthesia—Betaxolol—glaucoma	0.000357	0.000597	CcSEcCtD
Eprosartan—Syncope—Timolol—glaucoma	0.000356	0.000596	CcSEcCtD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000356	0.00558	CbGpPWpGaD
Eprosartan—Dyspnoea—Betaxolol—glaucoma	0.000354	0.000592	CcSEcCtD
Eprosartan—Nausea—Brinzolamide—glaucoma	0.000353	0.000591	CcSEcCtD
Eprosartan—Palpitations—Timolol—glaucoma	0.000351	0.000588	CcSEcCtD
Eprosartan—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000351	0.00551	CbGpPWpGaD
Eprosartan—Dyspepsia—Betaxolol—glaucoma	0.00035	0.000585	CcSEcCtD
Eprosartan—Loss of consciousness—Timolol—glaucoma	0.000349	0.000585	CcSEcCtD
Eprosartan—Cough—Timolol—glaucoma	0.000347	0.00058	CcSEcCtD
Eprosartan—Decreased appetite—Betaxolol—glaucoma	0.000345	0.000578	CcSEcCtD
Eprosartan—Fatigue—Betaxolol—glaucoma	0.000342	0.000573	CcSEcCtD
Eprosartan—Pain—Betaxolol—glaucoma	0.00034	0.000568	CcSEcCtD
Eprosartan—Constipation—Betaxolol—glaucoma	0.00034	0.000568	CcSEcCtD
Eprosartan—Nausea—Pilocarpine—glaucoma	0.000339	0.000568	CcSEcCtD
Eprosartan—Chest pain—Timolol—glaucoma	0.000338	0.000566	CcSEcCtD
Eprosartan—Myalgia—Timolol—glaucoma	0.000338	0.000566	CcSEcCtD
Eprosartan—Arthralgia—Timolol—glaucoma	0.000338	0.000566	CcSEcCtD
Eprosartan—Anxiety—Timolol—glaucoma	0.000337	0.000564	CcSEcCtD
Eprosartan—Hypersensitivity—Clonidine—glaucoma	0.000336	0.000562	CcSEcCtD
Eprosartan—Discomfort—Timolol—glaucoma	0.000334	0.000559	CcSEcCtD
Eprosartan—Dry mouth—Timolol—glaucoma	0.000331	0.000554	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—PTGFR—glaucoma	0.000329	0.00516	CbGpPWpGaD
Eprosartan—Asthenia—Clonidine—glaucoma	0.000327	0.000548	CcSEcCtD
Eprosartan—Feeling abnormal—Betaxolol—glaucoma	0.000327	0.000547	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—SMO—glaucoma	0.000323	0.00507	CbGpPWpGaD
Eprosartan—Pruritus—Clonidine—glaucoma	0.000323	0.00054	CcSEcCtD
Eprosartan—Shock—Timolol—glaucoma	0.000319	0.000534	CcSEcCtD
Eprosartan—ABCC2—NRF2 pathway—GSTM1—glaucoma	0.000318	0.00499	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—TNF—glaucoma	0.000317	0.00497	CbGpPWpGaD
Eprosartan—Urticaria—Betaxolol—glaucoma	0.000315	0.000528	CcSEcCtD
Eprosartan—Body temperature increased—Betaxolol—glaucoma	0.000314	0.000525	CcSEcCtD
Eprosartan—Hyperhidrosis—Timolol—glaucoma	0.000314	0.000525	CcSEcCtD
Eprosartan—Diarrhoea—Clonidine—glaucoma	0.000312	0.000522	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—LRP12—glaucoma	0.000312	0.00489	CbGpPWpGaD
Eprosartan—Anorexia—Timolol—glaucoma	0.000309	0.000517	CcSEcCtD
Eprosartan—Hypotension—Timolol—glaucoma	0.000303	0.000507	CcSEcCtD
Eprosartan—Dizziness—Clonidine—glaucoma	0.000302	0.000505	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Timolol—glaucoma	0.000296	0.000494	CcSEcCtD
Eprosartan—Insomnia—Timolol—glaucoma	0.000293	0.000491	CcSEcCtD
Eprosartan—Hypersensitivity—Betaxolol—glaucoma	0.000293	0.000489	CcSEcCtD
Eprosartan—Paraesthesia—Timolol—glaucoma	0.000291	0.000487	CcSEcCtD
Eprosartan—Vomiting—Clonidine—glaucoma	0.00029	0.000485	CcSEcCtD
Eprosartan—Dyspnoea—Timolol—glaucoma	0.000289	0.000484	CcSEcCtD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000289	0.00452	CbGpPWpGaD
Eprosartan—Somnolence—Timolol—glaucoma	0.000288	0.000483	CcSEcCtD
Eprosartan—Rash—Clonidine—glaucoma	0.000288	0.000481	CcSEcCtD
Eprosartan—Dermatitis—Clonidine—glaucoma	0.000287	0.000481	CcSEcCtD
Eprosartan—Headache—Clonidine—glaucoma	0.000286	0.000478	CcSEcCtD
Eprosartan—Dyspepsia—Timolol—glaucoma	0.000286	0.000478	CcSEcCtD
Eprosartan—Asthenia—Betaxolol—glaucoma	0.000285	0.000477	CcSEcCtD
Eprosartan—Decreased appetite—Timolol—glaucoma	0.000282	0.000472	CcSEcCtD
Eprosartan—Pruritus—Betaxolol—glaucoma	0.000281	0.00047	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00028	0.00439	CbGpPWpGaD
Eprosartan—Fatigue—Timolol—glaucoma	0.00028	0.000468	CcSEcCtD
Eprosartan—Pain—Timolol—glaucoma	0.000277	0.000464	CcSEcCtD
Eprosartan—Diarrhoea—Betaxolol—glaucoma	0.000272	0.000455	CcSEcCtD
Eprosartan—Nausea—Clonidine—glaucoma	0.000271	0.000453	CcSEcCtD
Eprosartan—Feeling abnormal—Timolol—glaucoma	0.000267	0.000447	CcSEcCtD
Eprosartan—Gastrointestinal pain—Timolol—glaucoma	0.000265	0.000444	CcSEcCtD
Eprosartan—Dizziness—Betaxolol—glaucoma	0.000263	0.000439	CcSEcCtD
Eprosartan—Urticaria—Timolol—glaucoma	0.000258	0.000431	CcSEcCtD
Eprosartan—Body temperature increased—Timolol—glaucoma	0.000256	0.000429	CcSEcCtD
Eprosartan—Abdominal pain—Timolol—glaucoma	0.000256	0.000429	CcSEcCtD
Eprosartan—Vomiting—Betaxolol—glaucoma	0.000252	0.000422	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000251	0.00394	CbGpPWpGaD
Eprosartan—Rash—Betaxolol—glaucoma	0.00025	0.000419	CcSEcCtD
Eprosartan—Dermatitis—Betaxolol—glaucoma	0.00025	0.000419	CcSEcCtD
Eprosartan—Headache—Betaxolol—glaucoma	0.000249	0.000416	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000245	0.00384	CbGpPWpGaD
Eprosartan—Hypersensitivity—Timolol—glaucoma	0.000239	0.0004	CcSEcCtD
Eprosartan—Nausea—Betaxolol—glaucoma	0.000236	0.000395	CcSEcCtD
Eprosartan—Asthenia—Timolol—glaucoma	0.000233	0.000389	CcSEcCtD
Eprosartan—Pruritus—Timolol—glaucoma	0.00023	0.000384	CcSEcCtD
Eprosartan—Diarrhoea—Timolol—glaucoma	0.000222	0.000371	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—OPN4—glaucoma	0.000216	0.00339	CbGpPWpGaD
Eprosartan—Dizziness—Timolol—glaucoma	0.000215	0.000359	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—EDN1—glaucoma	0.000213	0.00334	CbGpPWpGaD
Eprosartan—Vomiting—Timolol—glaucoma	0.000206	0.000345	CcSEcCtD
Eprosartan—Rash—Timolol—glaucoma	0.000205	0.000342	CcSEcCtD
Eprosartan—Dermatitis—Timolol—glaucoma	0.000204	0.000342	CcSEcCtD
Eprosartan—Headache—Timolol—glaucoma	0.000203	0.00034	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—HEYL—glaucoma	0.000201	0.00315	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTGFR—glaucoma	0.000194	0.00305	CbGpPWpGaD
Eprosartan—Nausea—Timolol—glaucoma	0.000193	0.000322	CcSEcCtD
Eprosartan—CYP2C9—Biological oxidations—GSTT1—glaucoma	0.000192	0.00302	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—C3—glaucoma	0.000186	0.00292	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	0.000186	0.00291	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000184	0.00288	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—SMO—glaucoma	0.000166	0.0026	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP1B1—glaucoma	0.000153	0.0024	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RPTOR—glaucoma	0.000152	0.00239	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	0.000151	0.00237	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NCK2—glaucoma	0.000147	0.00231	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000143	0.00225	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CA5A—glaucoma	0.000135	0.00211	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NARFL—glaucoma	0.000135	0.00211	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HDAC9—glaucoma	0.000125	0.00196	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—GSTM1—glaucoma	0.000123	0.00192	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	0.000121	0.00189	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—EDN1—glaucoma	0.000121	0.00189	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—EDN1—glaucoma	0.000109	0.00172	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—C3—glaucoma	0.000105	0.00165	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SMO—glaucoma	9.81e-05	0.00154	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—C3—glaucoma	9.56e-05	0.0015	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NTRK2—glaucoma	8.97e-05	0.00141	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NGFR—glaucoma	7.69e-05	0.00121	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NTRK1—glaucoma	7.31e-05	0.00115	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CDKN2B—glaucoma	6.74e-05	0.00106	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CA1—glaucoma	6.58e-05	0.00103	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EDN1—glaucoma	6.47e-05	0.00101	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CTSA—glaucoma	6.38e-05	0.001	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CA2—glaucoma	6.02e-05	0.000944	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NGF—glaucoma	5.94e-05	0.000932	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.89e-05	0.000923	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.89e-05	0.000923	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—C3—glaucoma	5.65e-05	0.000886	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOE—glaucoma	5.26e-05	0.000824	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CAV1—glaucoma	5.21e-05	0.000817	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FN1—glaucoma	4.96e-05	0.000777	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—BAD—glaucoma	4.9e-05	0.000768	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TXN—glaucoma	4.24e-05	0.000665	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NOS3—glaucoma	3.94e-05	0.000618	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.87e-05	0.000607	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.84e-05	0.000601	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CDKN1B—glaucoma	3.41e-05	0.000535	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTT1—glaucoma	3.29e-05	0.000516	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP9—glaucoma	3.16e-05	0.000496	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—VEGFA—glaucoma	2.84e-05	0.000445	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.65e-05	0.000416	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP1B1—glaucoma	2.62e-05	0.000411	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ABCA1—glaucoma	2.62e-05	0.000411	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TP53—glaucoma	2.14e-05	0.000336	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTM1—glaucoma	2.1e-05	0.000329	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MTHFR—glaucoma	1.85e-05	0.00029	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOE—glaucoma	1.72e-05	0.00027	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CAV1—glaucoma	1.71e-05	0.000268	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NOS3—glaucoma	1.29e-05	0.000203	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS2—glaucoma	1.18e-05	0.000185	CbGpPWpGaD
